1. Home
  2. LITE vs BBIO Comparison

LITE vs BBIO Comparison

Compare LITE & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITE
  • BBIO
  • Stock Information
  • Founded
  • LITE 2015
  • BBIO 2015
  • Country
  • LITE United States
  • BBIO United States
  • Employees
  • LITE N/A
  • BBIO N/A
  • Industry
  • LITE Telecommunications Equipment
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LITE Telecommunications
  • BBIO Health Care
  • Exchange
  • LITE Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • LITE 11.2B
  • BBIO 9.4B
  • IPO Year
  • LITE N/A
  • BBIO 2019
  • Fundamental
  • Price
  • LITE $164.80
  • BBIO $54.93
  • Analyst Decision
  • LITE Buy
  • BBIO Strong Buy
  • Analyst Count
  • LITE 14
  • BBIO 16
  • Target Price
  • LITE $143.46
  • BBIO $64.44
  • AVG Volume (30 Days)
  • LITE 2.9M
  • BBIO 1.9M
  • Earning Date
  • LITE 11-04-2025
  • BBIO 11-11-2025
  • Dividend Yield
  • LITE N/A
  • BBIO N/A
  • EPS Growth
  • LITE N/A
  • BBIO N/A
  • EPS
  • LITE 0.37
  • BBIO N/A
  • Revenue
  • LITE $1,645,000,000.00
  • BBIO $235,812,000.00
  • Revenue This Year
  • LITE $42.13
  • BBIO $115.46
  • Revenue Next Year
  • LITE $19.63
  • BBIO $65.03
  • P/E Ratio
  • LITE $445.81
  • BBIO N/A
  • Revenue Growth
  • LITE 21.03
  • BBIO 7.62
  • 52 Week Low
  • LITE $45.65
  • BBIO $21.72
  • 52 Week High
  • LITE $178.49
  • BBIO $57.49
  • Technical
  • Relative Strength Index (RSI)
  • LITE 58.07
  • BBIO 57.24
  • Support Level
  • LITE $153.32
  • BBIO $52.97
  • Resistance Level
  • LITE $165.03
  • BBIO $57.48
  • Average True Range (ATR)
  • LITE 9.17
  • BBIO 1.67
  • MACD
  • LITE -1.56
  • BBIO 0.04
  • Stochastic Oscillator
  • LITE 55.31
  • BBIO 61.83

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: